Skip to main content

$0.010 (0.00%)

High

$0.01

Low

$0.01

Trades

20

Turnover

$16,459

Volume

1,641,703
30 June 2023 at 4:10pm
Register to track PAB and receive email alerts.

PAT-DX1/Radiation Combination Improves Brain Cancer Survival

StockBot

416,823 posts

PAB released this announcement to the ASX on 10 August 2022, 9:36. The announcement is marked as price sensitive, and is 4 page(s) in length and 446.28kb in size.

You can view all announcements from PAB and see how they appear on a price chart on the announcements page.

At the date of this announcement, PAB was 0.001% short sold according to ASIC data. It was ranked the 659th most shorted stock on the ASX. It is now ranked as the 630th most shorted stock on the ASX with 0.002% of total shares short sold as of the latest reported data (24 January 2025).

Other Recent Announcements from PAB
PAT-DX1 GLP toxicology reports received 24 May 2023, 9:12
Notification regarding unquoted securities - PAB 11 May 2023, 14:04
Appendix 4C - Quarterly - 31 March 2023 24 April 2023, 10:10
PAT-DX1/Radiation Combination Improves Brain Cancer Survival 10 August 2022, 9:36
Retirement of Non-Executive Chair 8 August 2022, 9:07
Appendix 4C - Quarterly - 30 June 2022 28 July 2022, 9:03
Change in substantial holding 27 July 2022, 11:58
You must login or register to post a comment.

You must be logged in to post a reply.

Register to track PAB and receive email alerts.